Humankind US Stock ETF Rating $34.30 -0.20 (-0.57%) As of 10:18 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Humankind US Stock ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HKND Aggregate RatingModerate Buy 2.59Holdings in HKND have an aggregate rating of Moderate Buy based on 473 analyst ratings issued in the past year covering 24 companies (41.5% of the portfolio).HKND Aggregate Price Target$34.350.16% UpsideHigh Prediction$34.35Average Prediction$34.35Low Prediction$34.35Holdings in HKND have an aggregate price target of $34.35 and a range of $34.35 to $34.35 covering 24 companies (41.5% of the portfolio).HKND Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Humankind US Stock ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 HKND Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.04%GOOGLAlphabet$251.62+0.0%3.8906 of 5 stars2.84$222.85 -11.4%45Trending NewsAnalyst Upgrade3.40%ADMArcher Daniels Midland$60.520.0%3.8619 of 5 stars2.00$55.50 -8.3%8Positive News2.45%AAPLApple$239.44+1.2%4.695 of 5 stars2.56$241.77 1.0%32Trending NewsAnalyst Forecast2.26%LLYEli Lilly and Company$754.85+0.9%4.9965 of 5 stars2.70$947.39 25.5%23Trending NewsAnalyst Forecast2.19%BGBunge Global$80.14-0.2%4.3027 of 5 stars2.50$85.33 6.5%6Positive News2.17%ABBVAbbVie$216.57-0.5%4.7657 of 5 stars2.92$220.43 1.8%26Trending NewsAnalyst ForecastAnalyst Revision2.14%MSFTMicrosoft$512.63-0.5%4.9284 of 5 stars2.97$612.54 19.5%32Trending NewsDividend Increase2.14%JNJJohnson & Johnson$177.05-0.2%4.6849 of 5 stars2.65$176.29 -0.4%20Positive NewsAnalyst Upgrade1.70%PGProcter & Gamble$157.20+0.2%4.6325 of 5 stars2.67$175.12 11.4%18Positive News1.63%DEDeere & Company$468.38-0.2%4.6669 of 5 stars2.56$520.87 11.2%18Positive NewsAnalyst Upgrade1.61%INTCIntel$25.15+1.6%3.1713 of 5 stars1.85$22.17 -11.9%27Trending NewsAnalyst Upgrade1.47%ABTAbbott Laboratories$133.15+1.4%4.9221 of 5 stars2.91$144.47 8.5%22Positive News1.45%PFEPfizer$24.06+0.4%4.986 of 5 stars2.39$28.12 16.8%18Positive News1.38%BDXBecton, Dickinson and Company$186.79+0.6%4.953 of 5 stars2.36$211.44 13.2%11News CoveragePositive News1.35%MRKMerck & Co., Inc.$80.77-0.3%4.9979 of 5 stars2.35$107.44 33.0%20Positive News1.34%GEHCGE HealthCare Technologies$77.46-0.4%4.2408 of 5 stars2.91$88.40 14.1%11Positive News1.29%MOSMosaic$33.63-1.2%4.4983 of 5 stars2.79$36.42 8.3%14Positive NewsAnalyst Downgrade1.28%SYKStryker$377.61+0.1%4.9453 of 5 stars2.78$431.42 14.3%18Positive News1.16%TMOThermo Fisher Scientific$475.09+0.1%4.974 of 5 stars2.77$592.24 24.7%22Positive News1.05%CTVACorteva$69.89-0.3%4.7488 of 5 stars2.86$81.33 16.4%14News CoveragePositive NewsAnalyst Forecast1.01%BAXBaxter International$23.89+0.4%4.8471 of 5 stars2.20$30.11 26.1%10News CoveragePositive News1.01%AMGNAmgen$274.94+0.2%4.6605 of 5 stars2.24$304.43 10.7%21Positive News0.98%LHLabcorp$274.68-0.3%4.6456 of 5 stars2.62$290.33 5.7%13Positive News0.96%CVSCVS Health$72.68-1.1%4.9565 of 5 stars2.96$77.89 7.2%24Positive NewsAnalyst Downgrade This page (NYSEARCA:HKND) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humankind US Stock ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Humankind US Stock ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
